Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Captainblkon Feb 22, 2021 12:24pm
309 Views
Post# 32626931

Someone just added to their short position

Someone just added to their short position
$KLY.V KALYTERA THERAPEUTICS INC. 133,717 25,437 21 Feb 2021
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 4 Feb 2021
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 20 Jan 2021
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 6 Jan 2021
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 20 Dec 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 3 Dec 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 19 Nov 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 5 Nov 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 20 Oct 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 5 Oct 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 20 Sep 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 3 Sep 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 20 Aug 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 6 Aug 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 0 20 Jul 2020
$KLY.V KALYTERA THERAPEUTICS INC. 108,280 -148,000 6 Jul 2020
$KLY.V KALYTERA THERAPEUTICS INC. 256,280 -362,440 18 Jun 2020
$KLY.V KALYTERA THERAPEUTICS INC. 618,720 540,894 4 Jun 2020

This is interesting to me because it tells me a few things:

1) this stock has been halted since June 23 2020- yet shorters can apparently still make moves(july 6th they dumped 148k shares, and added 25k shares this week) how is this possible?

2) look at that big position taken at the start of june and then the big dump taken 2 business days before the halt- somebody knew something. this makes me think we have been betting against the ones who are supposed to be making us money and they have been intentionally driving the SP down to make their money on their shorts- then they pulled out when the halt was about to happen.

3) this case is reinforced with the recent pop on the US ticker that happened RIGHT before the morons at Sleezman accidently published the Claritas site- this shows that insiders were trying to ride the wave upwards after having riding it all the way down to the bank

this boom bust cycle seems like they are just trying to milk investors in both directions since they can control the health of the company(s) that we invest in-

 new name new angle, new product, new promise of gov't funding = new investors to attract = ride the SP up. 

once it tops out, maybe coupled with a RS they can short it, and then amplify that decent with NR's designed to be received poorly(KLY buying sleezman & Stero after telling investors they were being courted to be bought/partnered etc)



this recent short position doesnt indicate much beyond: how can someone be making moves right now while halted and someone expects a dip out of the gate(who doesnt but i suspect they cover between unhalting and an NR).

I believe we will see something soon if only for the fact that the recent Claritas leak(intentional or not to generate buzz from the slueths here), the fact that some insider(resumably decided to take a short position after an 8 month hiatas, and also the fact that some boards have become active again with users( a mix of real investors, and what I believe are paid pumpers and bashers probably hired by sleezman from some 3rd world country). I think they were probably pretty instrumental in driving the SP down prior to the halt(penny) and now pumpers are trying to bump the narrative up. notice the talk of NO from companies that have nothing to do with kly/claritas/sleezman? ask yourself does bitcoins success automatically mean success for another crypto ie Quadriga?

TBH I have a decent position and I hope im wrong- and I welcome people to poke real holes backed by evidence- because that will only create investor confidence. 

TL;DR; newly created short position might mean unhalt soon, followed by dip, followed by heavy NR and pumping and hopefully followed by an SP between 0.10-0.30

<< Previous
Bullboard Posts
Next >>